T1 Condition 702 717 RRAGC mutations
T2 Condition 911 915 EZH2
T3 Protein 844 852 SESTRIN1
T4 Condition 212 219 genetic
T5 Protein 618 622 mRNA
T6 Intervention 779 788 antitumor
T7 Condition 11 19 lymphoma
T8 Protein 291 299 SESTRIN1
T9 Gene 177 190 chromosome 6q
T10 Condition 356 361 tumor
T11 Protein 998 1008 RapaLink-1
T12 Protein 659 667 SESTRIN1
T13 Condition 458 488 EZH2 gain-of-function mutation
T14 Gene 870 876 mTORC1
T15 Condition 104 111 genetic
T16 Protein 377 385 SESTRIN1
T17 Biomarker 328 339 6q deletion
T18 Protein 1048 1056 SESTRIN1
T19 Condition 1076 1083 genetic
T20 Condition 196 205 mutations
T21 Condition 941 967 EZH2Y641X mutant lymphomas
T22 Condition 958 966 lymphoma
T23 Condition 817 821 EZH2
T24 Protein 21 23 FL
T25 Condition 490 494 EZH2
T26 Condition 261 268 genetic
T28 Condition 239 243 EZH2
T29 Condition 708 717 mutations
T30 Condition 1120 1128 lymphoma
T31 Gene 1110 1116 mTORC1
T32 Condition 49 64 B cell lymphoma
T33 Protein 502 510 SESTRIN1
T36 Condition 1091 1098 genetic
T37 Condition 458 462 EZH2
T38 Protein 123 125 FL
T39 Protein 1025 1039 mTOR inhibitor
T40 Gene 577 596 rapamycin complex 1
T41 Condition 104 119 genetic lesions
T42 Gene 66 73 Genomic
T43 Condition 919 927 lymphoma
T44 Condition 941 945 EZH2
T45 Condition 440 448 lymphoma
T46 Protein 405 413 SESTRIN1
T47 Gene 732 738 mTORC1
R1 Relation Arg1:T15 Arg2:T38
